• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[ABO/H blood groups and factor V Leiden].

作者信息

Matýsková M, Zavrelová J, Pejchalová A, Meluzinová H, Janků L

机构信息

Oddĕlení klinické hematologie FN, Brno.

出版信息

Cas Lek Cesk. 2002 Mar;141(5):146-51.

PMID:11998221
Abstract

BACKGROUND

Jick and his co-workers published in 1969 an observation showing the prevalence of blood group 0 being lower in people with thrombosis than in the healthy population. During the next years this finding was several times confirmed. The aim of our work was to answer the question on the distribution of blood groups in individuals with thrombophilia compared to the control group and whether the non-0 blood group increases the thrombosis risk in factor V Leiden carriers. We were also interested in mean values of the ProC Global test in different blood groups.

METHODS AND RESULTS

Factor V Leiden, prothrombin mutation 20210A and ProC Global were examined in individuals with thrombophilia. The blood group distribution was compared in thrombophilia and control groups. The distribution was statistically different (p = 0.000). The mean value of ProC Global in the non-0 carriers was lower than in persons with blood group 0.

CONCLUSION

There is a 1.76 times higher thrombosis risk (1/0.5697 = 1.76) in factor V Leiden carriers with blood group non-0 compared to blood group 0. The ProC Global mean values differ in patients with blood group 0 and in non-0 persons.

摘要

相似文献

1
[ABO/H blood groups and factor V Leiden].
Cas Lek Cesk. 2002 Mar;141(5):146-51.
2
AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.AB0血型与因子V莱顿突变或凝血酶原G20210A多态性携带者发生静脉或动脉血栓形成的风险
Haematologica. 2008 May;93(5):729-34. doi: 10.3324/haematol.12271. Epub 2008 Apr 2.
3
Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.抗磷脂抗体患者中的凝血因子V莱顿突变、凝血酶原基因突变与血栓形成风险
J Rheumatol. 2002 Aug;29(8):1683-8.
4
Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.重度卵巢过度刺激综合征女性血栓形成倾向的患病率及筛查的成本效益
Fertil Steril. 2004 Apr;81(4):989-95. doi: 10.1016/j.fertnstert.2003.09.042.
5
Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.遗传性血栓形成倾向与哥伦比亚人群的深静脉血栓形成有关。
Am J Hematol. 2006 Dec;81(12):933-7. doi: 10.1002/ajh.20733.
6
Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.埃及门静脉血栓形成儿童中因子V莱顿突变及其他遗传性血栓形成因素的患病率:一项单中心病例对照研究的结果
Ann Hematol. 2004 Nov;83(11):712-5. doi: 10.1007/s00277-004-0921-4. Epub 2004 Aug 10.
7
Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems.不同静脉系统血栓形成患者遗传性血栓形成倾向的患病率。
Am J Hematol. 2002 Jun;70(2):126-32. doi: 10.1002/ajh.10103.
8
Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups.血液透析血管通路血栓形成:因子 V 莱顿、凝血酶原基因突变和 ABO 血型的作用。
Clin Chim Acta. 2011 Feb 20;412(5-6):425-9. doi: 10.1016/j.cca.2010.11.002. Epub 2010 Nov 8.
9
Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.上肢原发性深静脉血栓形成的危险因素及复发率
Circulation. 2004 Aug 3;110(5):566-70. doi: 10.1161/01.CIR.0000137123.55051.9B. Epub 2004 Jul 19.
10
[Diagnosis of thrombophilia based on coagulation and genetic studies].基于凝血和基因研究的血栓形成倾向诊断
Ann Acad Med Stetin. 2002;48:179-93.